eyestock logo

eyestock

KR

Krebs Biochemicals and Industries LtdNSE KREBSBIO

Последний отчетный период 31 мар., 2024

Обновлено 04 нояб., 2024

Последняя цена

Капитализация млрд. $

0.018

Micro

Биржа

XNSE - National Stock Exchange Of India

Анализ акций KREBSBIO.NS

KR

Нет оценки

Количественный анализ Eyestock не покрывает акции Krebs Biochemicals and Industries Ltd.

Рейтинг

Для оценки качества бизнеса компании мы собрали все финансовые данные из отчетов и представили их в виде одного числа - рейтинга компании. Значение рейтинга 100 является пороговым для определения актуальной инвестиционной идеи.

-25/100

Низкий рейтинг

Капитализация млрд. $

0.018

Дивидендная доходность

Оборот

21.561 млрд

Сайт компании

http://krebsbiochem.com

Krebs Biochemicals & Industries Ltd. engages in the manufacture and sale of pharmaceutical ingredients and intermediates. The company is headquartered in Hyderabad, Telangana and currently employs 210 full-time employees. The firm develops commercially viable biotech processes for application in medicine, agriculture and industry. The company is also engaged in chemical synthesis, fermentation and enzymatic technologies. The company manufactures various products, such as Androstenedione for use as steroid intermediate, and Lovastatin and Simvastatin for anti-cholesterol. The company also undertakes contract manufacturing for pharmaceutical and multinational companies and developing products for sale in global markets. The company has also products in the pilot or research and development stages, which include Amlodipine, Cetirizine, Orlistat, Serratiopepetidase, Telmisartan and Phenylephrine. The company has two manufacturing facilities, one is located at Regadichelaka, Nellore District, and another one located at Kothapalli Village, Kasimkota Mandal, Visakhapatnam District, Andhra Pradesh, India.

Смотреть Секцию: Рейтинг